Firstly, low gene expression of the SARS-CoV-2 viral entry receptor angiotensin-converting-enzyme-2 (ACE2) is associated with atopic asthma, limiting the entry of coronavirus into the cell, thus leading to lesser COVID-19 severity [28]. This evidence concerns the gene ACE2 and COVID-19.